Search Results - "MALMSTRÖM, Henric"

Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer by GORE, Martin, TEN BOKKEL HUININK, Wim, MALFETANO, John, SCARABELLI, Claudio, VENNIN, Phillipe, ROSS, Graham, FIELDS, Scott Z, CARMICHAEL, James, GORDON, Alan, DAVIDSON, Neville, COLEMAN, Robert, SPACZYNSKI, Marek, HERON, Jean-Francois, BOLIS, Giorgio, MALMSTRÖM, Henric

“…A large, randomized study comparing the efficacy and safety of topotecan versus paclitaxel in patients with relapsed epithelial ovarian cancer showed that…”
Get full text

Granulosa cell tumors of the ovary: prognostic factors and outcome by Malmström, H, Högberg, T, Risberg, B, Simonsen, E

“…Granulosa and theca cell tumors of the ovary account for 2-3% of ovarian malignancies. This study includes 54 patients with the diagnosis of granulosa cell…”
Get more information

A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation by SORBE, Bengt, GRAFLUND, Marianne, NYGREN, Lisa, HORVATH, György, SWAHN, Marie, BOMAN, Karin, BANGSHÖJ, René, LOOD, Margareta, MALMSTRÖM, Henric

“…The purpose of this study was to assess the response rate, toxicity, progression-free survival (PFS) and overall survival (OS) in a series of advanced stage…”
Get full text

Phase II study of docetaxel weekly in combination with carboplatin every 3 weeks as first-line chemotherapy in stage IIB to stage IV epithelial ovarian cancer by Sorbe, Bengt, Graflund, Marianne, Horvath, György, Swahn, Marie, Boman, Karin, Bangshöj, René, Lood, Margareta, Malmström, Henric

“…The purpose of this study was to assess the response rate, toxicity, progression-free survival, and overall survival in a series of patients with…”
Get more information

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel by Bookman, M A, Malmström, H, Bolis, G, Gordon, A, Lissoni, A, Krebs, J B, Fields, S Z

“…Topotecan, a topoisomerase I inhibitor, was evaluated in a multicenter, phase II study of women with epithelial ovarian carcinoma who relapsed after one or two…”
Get more information

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer by ten Bokkel Huinink, W, Gore, M, Carmichael, J, Gordon, A, Malfetano, J, Hudson, I, Broom, C, Scarabelli, C, Davidson, N, Spanczynski, M, Bolis, G, Malmström, H, Coleman, R, Fields, S C, Heron, J F

“…Topotecan and paclitaxel were evaluated in a randomized, multicenter study of patients with advanced epithelial ovarian carcinoma who had progressed during or…”
Get more information

Phase II Study of Vinorelbine in the Treatment of Platinum-Resistant Ovarian Carcinoma by Sørensen, Peter, Høyer, Morten, Jakobsen, Anders, Malmström, Henric, Havsteen, Hanne, Bertelsen, Kamma

“…Objective. The purpose of this phase II study was to evaluate on an intent-to-treat basis the activity and toxicity of single-agent vinorelbine (VRL) as…”
Get full text

Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases by Blom, René, Guerrieri, Claudio, Stål, Olle, Malmström, Henric, Simonsen, Ernst

“…Aim.The authors analyzed in a retrospective manner the prognostic significance of p53 and mdm-2 expression, DNA ploidy, S-phase fraction (SPF), and traditional…”
Get full text

Fine-Needle Aspiration Cytology versus Core Biopsies in the Evaluation of Recurrent Gynecologic Malignancies by Malmström, Henric

“…Fine-needle aspiration (FNA) cytology for the diagnosis of malignant lesions has been used in gynecologic oncology for a long time. Core biopsies have also…”
Get full text

Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7 by Guerrieri, C, Frånlund, B, Malmström, H, Boeryd, B

“…We have investigated the use of inhibin and cytokeratin-7 (CK-7) in distinguishing endometrioid ovarian carcinomas (both typical and sex cord-like) form…”
Get more information

Invasive Cancer of the Vulva by ROSEN, C, MALMSTRÖM, H

“…This study comprised 328 patients with histologically confirmed primary invasive vulvar cancer, treated between 1948 and 1994. It retrospectively analyzes…”
Get full text

No evidence that amifostine influences the plasma pharmacokinetics of topotecan in ovarian cancer patients by ZACKRISSON, Anna-Lena, MALMSTRÖM, Henric, PETERSON, Curt

“…This aim of this study was to compare the pharmacokinetics of topotecan in the presence and absence of preceding amifostine to reduce the risk of side effects…”
Get full text

Malignant Mixed Müllerian Tumors of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 44 Cases by Blom, René, Guerrieri, Claudio, Stål, Olle, Malmström, Henric, Sullivan, Siw, Simonsen, Ernst

“…Aim.The authors retrospectively analyzed the prognostic significance of p53, mdm-2, DNA ploidy, S-phase fraction (SPF), and traditional clinical and pathologic…”
Get full text

Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer by Malmström, H, Carstensen, J, Simonsen, E

“…Peritoneal access devices (port-catheters) were subcutaneously implanted in 125 patients for intraperitoneal chemotherapy of ovarian cancer. In 98% of patients…”
Get more information

A phase II study of intraperitoneal carboplatin as adjuvant treatment in early-stage ovarian cancer patients by Malmström, H, Simonsen, E, Westberg, R

“…In a previously reported phase I study of carboplatin administered ip to patients with ovarian cancer at our clinic, it was determined that the recommended…”
Get more information

Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer by Malmström, H, Rasmussen, S, Simonsen, E

“…Several randomized trials of various malignancies treated with cisplatin indicate a dose-response relationship with higher MST and longer survival achieved…”
Get more information

Phase I study of intraperitoneal carboplatin as adjuvant therapy in early ovarian cancer by Malmström, H, Larsson, D, Simonsen, E

“…Early stage poor-risk ovarian cancer patients are at considerable risk for recurrent disease. Adjuvant radio- or chemotherapy has been found to improve…”
Get more information

Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators by Malmström, H, Schmidt, H, Persson, P G, Carstensen, J, Nordenskjöld, B, Simonsen, E

“…Flow cytometry of various gynecological tumors has shown that aneuploid tumors and a high S-phase rate carry a prognosis worse than that of diploid tumors or…”
Get more information

Human placental lactogen serum levels in venous and capillary blood from women in late pregnancy by Axelsson, O, Malmström, H

“…The concentration of human placental lactogen (HPL), in serum was measured in venous and capillary blood from 31 pregnant women. 14 women had uncomplicated…”
Get more information

Choriocarcinoma presenting with cerebral metastases after full-term pregnancy by Pihl, K, Malmström, H, Simonsen, E

“…Choriocarcinoma is a rare malignancy in Scandinavia. We present a case of a young primigravida who experienced an uneventful pregnancy and gave birth to a…”
Get more information